E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research 


Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients

Jayun M Joshi, Harsh M Joshi, Hetal Patel, Param S Patel.

Abstract
Background: Contraception is the intentional use of artificial methods or other techniques to prevent pregnancy as a consequence of sexual intercourse. Progesterone only injectables are highly effective in preventing in pregnancy as they do not rely on daily usage of contraceptions as such as oral contraceptive pills and barrier methods. Injection depot-medroxyprogesterone acetate (DMPA) is an effective contraceptive method in lactating mother and postabortal patients.

Aims and Objectives: The aims of this study were to study utilization pattern, acceptance, effectiveness, and adverse effects of DMPA in postpartum and postabortal women.

Materials and Methods: It was a prospective and observational single-center study and was conducted at tertiary care teaching hospital. The data were collected in patient received Inj. DMPA 150 mg intra muscularly immediately after abortion and delivery before discharge. The follow-up was done after administration of DMPA (usually every 3 months).

Results: In this study, 56 (53.34%) patients were in the age group of 18–25 years, while 38 (36.19%) patients were 26–35 years whereas 11 (10.47%) were more than 36 years. Out of 105 patients, 12 patients were administered only one injection, 16 patients administered two injections and 16 patients given three injections of DMPA. Common adverse effects of DMPA are irregular bleeding (43.8%), amenorrhea (22.8%), and heavy bleeding (5.7%). Out of 24 patient who developed amenorrhea after injections of DMPA, total 11 patients had amenorrhea after fourth injection, 5 patients after first injection, and 2 patients after second injection of DMPA. Average time for return of fertility after last injection of DMPA was 9 months.

Conclusion: DMPA is very effective contraceptive and apart from menstrual troubles that there are no significant major side (weight gain, mood changes, etc.) effects related to its use. DMPA may cause a delay in the return of fertility, the return of fertility takes 7–10 months from date of last injection, but it is completely reversible.

Key words: Contraception; Depot-Medroxyprogesterone Acetate; Postpartum; Postabortal


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Jayun M Joshi
Articles by Harsh M Joshi
Articles by Hetal Patel
Articles by Param S Patel
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Joshi JM, Joshi HM, Patel H, Patel PS. Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. Natl J Physiol Pharm Pharmacol. 2023; 13(1): 197-203. doi:10.5455/njppp.2023.13.11562202230112022


Web Style

Joshi JM, Joshi HM, Patel H, Patel PS. Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. https://www.njppp.com/?mno=132511 [Access: February 01, 2023]. doi:10.5455/njppp.2023.13.11562202230112022


AMA (American Medical Association) Style

Joshi JM, Joshi HM, Patel H, Patel PS. Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. Natl J Physiol Pharm Pharmacol. 2023; 13(1): 197-203. doi:10.5455/njppp.2023.13.11562202230112022



Vancouver/ICMJE Style

Joshi JM, Joshi HM, Patel H, Patel PS. Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. Natl J Physiol Pharm Pharmacol. (2023), [cited February 01, 2023]; 13(1): 197-203. doi:10.5455/njppp.2023.13.11562202230112022



Harvard Style

Joshi, J. M., Joshi, . H. M., Patel, . H. & Patel, . P. S. (2023) Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. Natl J Physiol Pharm Pharmacol, 13 (1), 197-203. doi:10.5455/njppp.2023.13.11562202230112022



Turabian Style

Joshi, Jayun M, Harsh M Joshi, Hetal Patel, and Param S Patel. 2023. Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. National Journal of Physiology, Pharmacy and Pharmacology, 13 (1), 197-203. doi:10.5455/njppp.2023.13.11562202230112022



Chicago Style

Joshi, Jayun M, Harsh M Joshi, Hetal Patel, and Param S Patel. "Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 197-203. doi:10.5455/njppp.2023.13.11562202230112022



MLA (The Modern Language Association) Style

Joshi, Jayun M, Harsh M Joshi, Hetal Patel, and Param S Patel. "Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients." National Journal of Physiology, Pharmacy and Pharmacology 13.1 (2023), 197-203. Print. doi:10.5455/njppp.2023.13.11562202230112022



APA (American Psychological Association) Style

Joshi, J. M., Joshi, . H. M., Patel, . H. & Patel, . P. S. (2023) Effectiveness and follow-up of depot medroxyprogesterone acetate in postpartum and postabortal patients. National Journal of Physiology, Pharmacy and Pharmacology, 13 (1), 197-203. doi:10.5455/njppp.2023.13.11562202230112022